Uripay 200 Tablet 200 mg
Flavoxate Hydrochloride
Category: Tablet
Manufacturer: Al-Madina Pharmaceuticals Ltd.
Al-Madina Pharmaceuticals Ltd.
Allopathic
MFG. Licence No. Biological
266
Address
1/1, Tilargati, Tongi, Gazipur
Price: 15.0 ৳
2 x 10 in Blister Pack
Medicine Selling service is not available yet.
Related Medicines
Uses of Uripay 200 Tablet:
- Muscle spasms of the urinary tract
Cystitis, Urinary incontinence, Urgency and frequency, Bladder spasms, Dysuria, Nocturia, Suprapubic pain, Prostatitis, Urethritis
Pyloric or duodenal obstruction; obstructive intestinal lesions or ileus; achalasia; GI haemorhrage or obstructive uropathies of the lower urinary tract; myasthenia gravis; severe ulcerative colitis; toxic megacolon; glaucoma; children <12.
BPH/ Urinary retention/ Urinary incontinence
Flavoxate acts as a direct antagonist at muscarinic acetylcholine receptors in cholinergically innervated organs. Its anticholinergic-parasympatholytic action reduces the tonus of smooth muscle in the bladder, effectively reducing the number of required voids, urge incontinence episodes, urge severity and improving retention, facilitating increased volume per void.
How to use
Flavoxate Hydrochloride:
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.
Flavoxate Hydrochloride is to be taken with food.
Administration:
May be taken with or without food.
Adult Dose:
Oral
Adult:
Overactive Bladder
Indicated for dysuria, increased urinary frequency/incontinence, nocturia, suprapubic pain, urinary incontinence, urinary tract irritation, urinary urgency
100-200 mg PO q6-8hr
Child Dose:
Dysuria, Urinary Frequency
Indicated for dysuria, increased urinary frequency, nocturia, suprapubic pain, urinary incontinence, urinary tract irritation, urinary urgency
<12 years: Not recommended; safety and efficacy not established
>12 years: 100-200 mg PO q6-8hr
Amantadine, some antihistamines, phenothiazine antipsychotics, tricyclic antidepressants, MAOIs; parasympathomimetics. May decrease gastric motility thus decreasing absorption of certain drugs. May antagonise the GI effects of cisapride, domperidone, metoclopramide.
Pyloric or duodenal obstruction; obstructive intestinal lesions or ileus; achalasia; GI haemorhrage or obstructive uropathies of the lower urinary tract; myasthenia gravis; severe ulcerative colitis; toxic megacolon; glaucoma; children <12.
Common
- Nausea
- Vomiting
- Dryness in mouth
- Headache
- Drowsiness
- Dizziness
- Blurred vision
- Nervousness
Increased intraocular pressure; difficulty in ocular accommodation; blurred vision; dry mouth and throat; GI disturbances; nervousness; vertigo; headache; fatigue; confusion; hypersensitivity reactions; dysuria; tachycardia; palpitation; hyperpyrexia; eosinophilia; leukopenia, abdominal pain, constipation and difficulty in concentrating.
Pregnancy: Pregnancy Category B. This drug should be used during pregnancy only if clearly needed.Nursing Mothers: It is not known whether this drug is excreted in human milk. Caution should be exercised when flavoxate is administered to a nursing woman.
Precaution:
May affect ability to drive or operate machinery. May worsen hyperthyroidism, coronary artery disease, congestive heart failure, prostatic hypertrophy, arrhythmias, tachycardia. Pregnancy; lactation; elderly; autonomic neuropathy; hiatus hernia with reflux esophagitis, hepatic and renal impairment.
Lactation: not known if excreted in breast milk, use caution
Store Flavoxate at room temperature, between 20 and 25 degrees C
BPH/ Urinary retention/ Urinary incontinence
Flavoxate is a tertiary amine that acts as a smooth muscle relaxant; it also has antimuscarinic effects. It exhibits local anaesthetic, analgesic and spasmolytic effects.
Pregnancy Category: B
Lactation: not known if excreted in breast milk, use caution
Samm Care